IHC of Hepatocyte Specific Antigen on an FFPE Liver Tissue

IHC of Hepatocyte Specific Antigen on an FFPE Liver Tissue

United States
International
Research Use
Safety Data Sheet

SDS

Intended Use For In Vitro Diagnostic Use
Summary and Explanation Hepatocyte Specific Antigen (HSA or Hep Par 1) has been demonstrated consistently in the vast majority of Hepatocellular Carcinomas. Studies have shown the utility of HSA in the differential diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Hepatoblastomas. HSA recognizes both benign and malignant liver derived tissues including such tumors as Hepatoblastoma, Hepatocellular Carcinoma, and Hepatic Adenoma. It recognizes both normal adult and fetal liver tissue. The typical pattern is a granular cytoplasmic staining. This antibody is useful in differentiating Hepatocellular Carcinomas with adenoid features from Adenocarcinomas, either primary in the liver or metastatic lesions to the liver. In recognizing Hepatoblastoma, it is useful in differentiating this entity from other small round cell tumors.
Antibody Type Mouse Monoclonal Clone OCH1E5
Isotype IgG1/K Reactivity Paraffin, Frozen
Localization Cytoplasmic Control Liver, Liver Carcinoma
Presentation Anti-Hepatocyte Specific Antigen is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Availability
Catalog No. Antibody Type Dilution Volume/QTY
BSB 5624 Prediluted Ready-To-Use 3.0 ml
BSB 5625 Prediluted Ready-To-Use 7.0 ml
BSB 5626 Prediluted Ready-To-Use 15.0 ml
BSB 5627 Concentrated 1:100-1:500 0.1 ml
BSB 5628 Concentrated 1:100-1:500 0.5 ml
BSB 5629 Concentrated 1:100-1:500 1.0 ml
BSB 5630 Control Slides 5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.
Related Products